U.S. pharma big copyright scrapped two experimental weight loss supplements past year—a once-each day pill, lotiglipron, as a result of elevated liver enzymes in addition to a 2 times-every day pill, danuglipron, due to sturdy side effects—but CEO Albert Bourla has said the company i